About this episode

This episode discusses the practical use of long-acting injectable antipsychotics in schizophrenia, focusing on aripiprazole and olanzapine formulations.

In this episode, we explore the practical use of long-acting injectable antipsychotics in schizophrenia — specifically aripiprazole and olanzapine formulations. What's the right dose when a patient misses an injection? Dr. Brian Miller breaks down dosing, oral supplementation windows, and dose equivalence for Abilify Maintena, Aristada, and Zyprexa Relprevv. Faculty: Brian Miller, M.D., Ph.D., M.P.H. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Use of Long-Acting Injectable Antipsychotics in Schizophrenia LAIs in Practice: Aripiprazole & Olanzapine

More episodes of Psychopharmacology and Psychiatry Updates

• Is High-Dose Olanzapine A Clozapine Alternative? · July 20, 2026 · 11 min
• CANMAT Guidelines: Herbs, Supplements, and Depression · July 15, 2026 · 8 min
• Xylazine in the ED: Managing Toxicity · July 10, 2026 · 9 min
• Choosing the First Step in Depression Treatment: A CANMAT Guide · July 5, 2026 · 19 min
• After Delirium Clears: When to Deprescribe? · June 30, 2026 · 15 min
• The Clinician's Guide to Paliperidone & Risperidone LAIs · June 25, 2026 · 15 min

Explore listener stats, chart rankings, contacts and more on the Psychopharmacology and Psychiatry Updates podcast page.